Novartis AG Q2 2019 Earnings Call Transcript - Thomson StreetEvents

Novartis AG Q2 2019 Earnings Call Transcript

Novartis AG Q2 2019 Earnings Call Transcript - Thomson StreetEvents
Novartis AG Q2 2019 Earnings Call Transcript
Published Jul 18, 2019
24 pages (16726 words) — Published Jul 18, 2019
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of NOVN.S earnings conference call or presentation 18-Jul-19 12:00pm GMT

  
Brief Excerpt:

...Operator Good afternoon and welcome to the Novartis Q2 2019 Results Release Conference Call and Live Audio Webcast. (Operator Instructions) And the conference is being recorded. (Operator Instructions) A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. (Operator Instructions) With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations. Please go ahead, sir....

  
Report Type:

Transcript

Source:
Company:
Novartis AG
Ticker
NOVN.S
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Novartis AG ESG Investor Event Transcript – 2020-09-01 – US$ 54.00 – Edited Transcript of NOVN.S corporate analyst meeting</ 1-Sep-20 12:00pm GMT

Novartis AG to Discuss Kesimpta® FDA Approval Investor Call Transcript – 2020-08-21 – US$ 54.00 – Edited Transcript of NOVN.S conference call or presentation 21-Aug-20 2:30pm GMT

Novartis AG Q2 2020 Earnings Call Transcript – 2020-07-21 – US$ 54.00 – Edited Transcript of NOVN.S earnings conference call or presentation 21-Jul-20 12:00pm GMT

Novartis AG to Discuss the Oncology Pipeline Update Call Transcript – 2020-06-15 – US$ 54.00 – Edited Transcript of NOVN.S conference call or presentation 15-Jun-20 1:00pm GMT

Novartis AG Q2 2019 Earnings Call Summary – 2019-07-18 – US$ 54.00 – Edited Brief of NOVN.S earnings conference call or presentation 18-Jul-19 12:00pm GMT

Novartis AG to Discuss the Zolgensma® and Piqray® US FDA Approvals Call Summary – 2019-05-27 – US$ 54.00 – Edited Brief of NOVN.S conference call or presentation 27-May-19 2:30pm GMT

Novartis AG to Discuss the Zolgensma® and Piqray® US FDA Approvals Call Transcript – 2019-05-27 – US$ 54.00 – Edited Transcript of NOVN.S conference call or presentation 27-May-19 2:30pm GMT

Novartis AG Mayzent FDA Approval Investor Call Transcript – 2019-03-27 – US$ 54.00 – Edited Transcript of NOVN.S conference call or presentation 27-Mar-19 11:45am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Novartis AG Q2 2019 Earnings Call Transcript" Jul 18, 2019. Alacra Store. May 12, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2019-Novartis-AG-Earnings-Call-T12606506>
  
APA:
Thomson StreetEvents. (2019). Novartis AG Q2 2019 Earnings Call Transcript Jul 18, 2019. New York, NY: Alacra Store. Retrieved May 12, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2019-Novartis-AG-Earnings-Call-T12606506>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.